These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137 [TBL] [Abstract][Full Text] [Related]
7. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299 [TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159 [TBL] [Abstract][Full Text] [Related]
9. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Strauss J; Kaplan GG; Beck PL; Rioux K; Panaccione R; Devinney R; Lynch T; Allen-Vercoe E Inflamm Bowel Dis; 2011 Sep; 17(9):1971-8. PubMed ID: 21830275 [TBL] [Abstract][Full Text] [Related]
10. Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840 [TBL] [Abstract][Full Text] [Related]
12. Association of Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis. Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993 [TBL] [Abstract][Full Text] [Related]
14. Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205 [TBL] [Abstract][Full Text] [Related]
15. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer. Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787 [TBL] [Abstract][Full Text] [Related]
16. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. Zanzoni A; Spinelli L; Braham S; Brun C Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925 [TBL] [Abstract][Full Text] [Related]
17. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893 [TBL] [Abstract][Full Text] [Related]
18. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118 [TBL] [Abstract][Full Text] [Related]
19. Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644 [TBL] [Abstract][Full Text] [Related]
20. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Gur C; Ibrahim Y; Isaacson B; Yamin R; Abed J; Gamliel M; Enk J; Bar-On Y; Stanietsky-Kaynan N; Coppenhagen-Glazer S; Shussman N; Almogy G; Cuapio A; Hofer E; Mevorach D; Tabib A; Ortenberg R; Markel G; Miklić K; Jonjic S; Brennan CA; Garrett WS; Bachrach G; Mandelboim O Immunity; 2015 Feb; 42(2):344-355. PubMed ID: 25680274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]